首页 > 市场调查报告书 > 製药

疫苗

市场调查报告书

商品编码

1514926

治疗性蛋白质和口服疫苗市场，按治疗性蛋白质类型、递送方式、应用、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Therapeutic Proteins and Oral Vaccines Market, By Therapeutic Protein Type, By Delivery Method, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年06月11日 | 出版商:

AnalystView Market Insights | 英文 393 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

报告要点

2023 年治疗性蛋白质和口服疫苗市场规模为 2.5145 亿美元，2024 年至 2032 年复合年增长率为 7.9%。

治疗性蛋白质与口服疫苗市场-市场动态

个人化医疗和轻鬆预防推动治疗性蛋白质和口服疫苗市场成长

使用治疗性蛋白质和口服疫苗的个人化医疗和简单的预防策略正在推动医疗保健市场的繁荣。美国癌症协会的资料显示，CAR-T 细胞疗法（一种个人化蛋白质疗法）在某些白血病中实现了 80% 的缓解率。此外，世界卫生组织 2023 年的一份报告表明，口服疫苗由于其用户友好性，可以将发展中国家的儿童免疫率提高 20%。个人化治疗和方便的预防方法的结合正在推动治疗性蛋白质和口服疫苗领域的大量投资并推动市场成长。

治疗性蛋白质和口服疫苗市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 7.9% 左右的复合年增长率成长

根据治疗性蛋白质类型细分，预计单株抗体将在 2023 年显示最大的市场份额

根据给药方式细分，注射剂是 2023 年的主导类型

按地区划分，北美是 2023 年的主要收入来源

治疗性蛋白质和口服疫苗市场細項分析：

全球治疗性蛋白质和口服疫苗市场根据治疗性蛋白质类型、递送方法、应用和地区进行细分。

根据治疗蛋白质类型，市场分为六类：单株抗体、酵素、生长因子、干扰素、白血球介素和疫苗。单株抗体因其治疗各种癌症和自体免疫疾病的标靶方法而在治疗蛋白领域占据主导地位。酵素在治疗代谢紊乱方面越来越受到关注，而生长因子则有望在组织再生方面发挥作用。干扰素和白血球介素在免疫调节方面显示出潜力，而疫苗，尤其是口服疫苗，正在彻底改变预防保健。

根据给药方式，市场分为三类：注射、吸入和局部应用。由于精确的剂量控制和有效性，注射仍然是治疗性蛋白质的主要递送方法。吸入治疗呼吸系统疾病越来越受到关注，而局部应用则为局部治疗提供了便利。

治疗性蛋白质和口服疫苗市场 - 地理洞察

由于医疗保健支出高、慢性病盛行率上升以及研究基础设施完善等因素，北美占比重最高。然而，在可支配收入增加、政府医疗保健计划和大量患者人口的推动下，亚太地区等地区正在经历快速增长。欧洲高度重视生物製药开发，拥有稳定成长的成熟市场。由于未满足的医疗需求和政府对医疗保健的投资不断增加，非洲和拉丁美洲的发展中国家具有巨大的潜力。公司在这个市场上的成功将取决于他们遵守地区法规、制定适应不同经济状况的定价策略以及建立合作伙伴关係以确保更广泛的可及性的能力。

治疗性蛋白质与口服疫苗市场-竞争格局：

治疗性蛋白质和口服疫苗市场是一个竞争激烈的舞台，安进、辉瑞和强生等老牌製药巨头都在争夺主导地位。这些参与者利用其大量的研发预算来开发创新疗法和口服疫苗。併购是另一项策略性倡议，例如辉瑞收购了一家领先的镰状细胞治疗公司。此外，规模较小的生技公司不断涌现，推出了有前景的利基解决方案，营造了一个充满活力的环境。这些参与者与学术机构和政府机构之间的合作对于加速研究和发展至关重要。由于生物相似药日益受到关注，竞争格局进一步加剧，生物相似药为现有蛋白质疗法提供了具有成本效益的替代品。这不仅对定价带来压力，也迫使企业不断创新和差异化产品。

市场片段
- 治疗性蛋白质和口服疫苗市场片段（依治疗性蛋白质类型）
- 按交付方式分類的治疗性蛋白质和口服疫苗市场片段
- 治疗性蛋白质和口服疫苗市场片段（按应用）
- 按国家/地区分類的治疗性蛋白质和口服疫苗市场片段
- 按地区分類的治疗性蛋白质和口服疫苗市场片段
竞争洞察

第 3 章：治疗性蛋白质和口服疫苗主要市场趋势

治疗性蛋白质和口服疫苗市场驱动因素
- 市场驱动因素的影响分析
治疗性蛋白质和口服疫苗市场限制
- 市场限制影响分析
治疗性蛋白质和口服疫苗的市场机会
治疗性蛋白质与口服疫苗市场未来趋势

第 4 章：治疗性蛋白质与口服疫苗产业研究

PEST分析
波特五力分析
成长前景图
规范架构分析

第 5 章：治疗性蛋白质与口服疫苗市场：COVID-19 影响分析

COVID-19 之前的影响分析
COVID-19 后影响分析
- 表现最佳的市场区隔
- 边际增长部分
- 最鬆散的部分
- 边际损失部分

第 6 章：治疗性蛋白质与口服疫苗市场格局

2023 年治疗性蛋白质和口服疫苗市场份额分析
按主要製造商分類的故障数据
- 既定玩家分析
- 新兴玩家分析

第 7 章：治疗性蛋白质和口服疫苗市场 - 按治疗性蛋白质类型

概述
- 按治疗性蛋白质类型分類的细分市场份额分析
- 单株抗体
- 酵素
- 生长因子
- 干扰素
- 白血球介素
- 疫苗

第 8 章：治疗性蛋白质和口服疫苗市场 - 按交付方式

概述
- 按交付方式分類的细分市场份额分析
- 注射
- 吸入
- 局部应用

第 9 章：治疗性蛋白质和口服疫苗市场 - 按应用

概述
- 按应用分類的细分市场占有率分析
- 癌症
- 自体免疫疾病
- 传染性疾病
- 神经系统疾病
- 代谢紊乱
- 其他疾病

第 10 章：治疗性蛋白质和口服疫苗市场 - 按地理位置

介绍
- 按地理位置分類的细分市场占有率分析
北美洲
- 概述
- 北美治疗性蛋白质和口服疫苗主要製造商
- 北美市场规模和预测（按国家）
- 北美市场规模与预测（按治疗性蛋白质类型）
- 北美市场规模和预测（按交付方式）
- 北美市场规模和预测（按应用）
- 我们
- 加拿大
欧洲
- 概述
- 欧洲治疗性蛋白质和口服疫苗的主要製造商
- 欧洲市场规模和预测（按国家）
- 欧洲市场规模与预测（按治疗性蛋白质类型）
- 欧洲市场规模和预测（按交付方式）
- 欧洲市场规模和预测（按应用）
- 德国
- 义大利
- 英国
- 法国
- 俄罗斯
- 荷兰
- 瑞典
- 波兰
- 欧洲其他地区
亚太地区 (APAC)
- 概述
- 亚太地区治疗性蛋白质和口服疫苗主要製造商
- 亚太地区市场规模与预测（按国家）
- 亚太地区市场规模与预测（按治疗性蛋白质类型）
- 亚太地区市场规模与预测（以交付方式）
- 亚太地区市场规模与预测（按应用）
- 印度
- 中国
- 日本
- 韩国
- 澳洲
- 泰国
- 印尼
- 菲律宾
- 亚太地区其他地区
拉丁美洲
- 概述
- 拉丁美洲治疗性蛋白质和口服疫苗的主要製造商
- 拉丁美洲市场规模与预测（按国家）
- 拉丁美洲市场规模与预测（按治疗性蛋白质类型）
- 拉丁美洲市场规模和预测（以交付方式）
- 拉丁美洲市场规模与预测（按应用）
- 巴西
- 墨西哥
- 阿根廷
- 哥伦比亚
- 拉丁美洲其他地区
中东和非洲
- 概述
- 中东和非洲治疗性蛋白质和口服疫苗的主要製造商
- 中东和非洲市场规模及预测（按国家）
- 中东和非洲市场规模及预测（按治疗性蛋白质类型）
- 中东和非洲市场规模及预测（以交付方式）
- 中东和非洲市场规模及预测（按应用）
- 沙乌地阿拉伯
- 阿拉伯聯合大公国
- 以色列
- 土耳其
- 阿尔及利亚
- 埃及
- MEA 的其余部分

第 11 章：主要供应商分析 - 治疗性蛋白质和口服疫苗产业

竞争仪表板
公司简介
- Abbott Laboratories
- Amgen Inc.
- Biogen Inc.
- Eli Lilly and Company
- Emergent Biosolutions Inc.
- F. Hoffmann-La Roche Ltd
- Johnson & Johnson
- Lumen Bioscience Inc.
- Merck & Co., Inc.
- MigVax Ltd
- Neurelis Inc.
- Novo Nordisk A/S
- Pfizer Inc.
- Sanofi SA
- Serum Institute of India Pvt. Ltd.
- TransAlgae
- Others

第 12 章：360 度分析师视角

第 13 章：附录

研究方法论
参考
缩写
免责声明
联络我们

简介目录图表

Product Code: ANV2997

REPORT HIGHLIGHT

Therapeutic Proteins and Oral Vaccines Market size was valued at USD 251.45 Million in 2023, expanding at a CAGR of 7.9% from 2024 to 2032.

The Therapeutic Proteins and Oral Vaccines market encompasses treatments utilizing proteins and convenient oral vaccines. This growth is fueled by the rising need for these therapies, particularly in cancer, diabetes, and infectious diseases. Increased clinical trials, advancements in protein engineering, and growing government support for research are propelling the market forward. However, high manufacturing costs and stringent regulatory hurdles pose challenges. Despite these, the potential for personalized medicine using therapeutic proteins and the growing demand for needle-free vaccination present exciting market opportunities.

Therapeutic Proteins and Oral Vaccines Market- Market Dynamics

Personalized Medicine & Easy Prevention Drive Therapeutic Protein & Oral Vaccine Market Growth

Personalized medicine and easy prevention strategies using therapeutic proteins and oral vaccines are fueling a boom in the healthcare market. American Cancer Society data shows CAR-T cell therapy, a personalized protein treatment, achieving an 80% remission rate in some leukemias. Furthermore, a 2023 World Health Organization report suggests oral vaccines could raise childhood immunization rates in developing countries by 20% due to their user-friendliness. This confluence of personalized treatments and convenient preventative methods is driving substantial investment and propelling market growth within the Therapeutic Protein and Oral Vaccine sectors.

Therapeutic Proteins and Oral Vaccines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.9% over the forecast period (2024-2032)

Based on Therapeutic Protein Type segmentation, Monoclonal Antibodies were predicted to show maximum market share in the year 2023

Based on Delivery Method segmentation, Injections were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Therapeutic Proteins and Oral Vaccines Market- Segmentation Analysis:

The Global Therapeutic Proteins and Oral Vaccines Market is segmented based on Therapeutic Protein Type, Delivery Method, Application, and Region.

The market is divided into six categories based on Therapeutic Protein Type: Monoclonal Antibodies, Enzymes, Growth Factors, Interferons, Interleukins, and Vaccines. Monoclonal antibodies dominate the therapeutic protein segment due to their targeted approach to treating various cancers and autoimmune diseases. Enzymes are gaining traction for metabolic disorders, while growth factors hold promise in tissue regeneration. Interferons and interleukins show potential in immunomodulation, and vaccines, especially oral ones, are revolutionizing preventative care.

The market is divided into three categories based on Delivery Method: Injection, Inhalation, and Topical application. Injections remain the dominant delivery method for therapeutic proteins due to precise dosage control and effectiveness. Inhalation is gaining traction for respiratory diseases, while topical applications offer convenience for localized treatment.

Therapeutic Proteins and Oral Vaccines Market- Geographical Insights

North America holds the highest share due to factors like high healthcare expenditure, rising chronic disease prevalence, and established research infrastructure. However, regions like Asia Pacific are experiencing rapid growth fueled by increasing disposable income, government healthcare initiatives, and a large patient population. Europe, with its strong focus on biopharmaceutical development, presents a mature market with steady growth. Developing countries in Africa and Latin America offer significant potential due to unmet medical needs and growing government investments in healthcare. The success of companies in this market will depend on their ability to navigate regional regulations, develop pricing strategies that cater to varying economic landscapes, and establish partnerships to ensure wider accessibility.

Therapeutic Proteins and Oral Vaccines Market- Competitive Landscape:

The Therapeutic Proteins and Oral Vaccines market is a competitive arena with established pharmaceutical giants like Amgen, Pfizer, and Johnson & Johnson vying for dominance. These players leverage their extensive R&D budgets to develop innovative therapies and oral vaccines. Mergers and acquisitions are another strategic move, for instance, Pfizer's acquisition of a leading sickle cell therapy company. Additionally, smaller biotechnology firms are emerging with promising niche solutions, fostering a dynamic environment. Collaboration between these players, with academic institutions and government agencies, is crucial for accelerating research and development. The competitive landscape is further intensified by the growing focus on biosimilars, which offer cost-effective alternatives to established protein therapies. This not only puts pressure on pricing but also compels companies to constantly innovate and differentiate their products.

Recent Developments:

In January 2022, Amgen Inc., a biotechnology company, and Generate Biomedicines, a drug generation company, announced a research collaboration agreement to discover and create protein therapeutics for five clinical targets across various disease areas.

In November 2022, Merck & Co., Inc. announced that it would acquire Imago BioSciences, Inc., a clinical-stage biopharmaceutical company developing new medicines for the treatment of myeloproliferative neoplasms, for approximately USD 1.35 billion. Imago's lead candidate, bomedemstat, is an investigational orally available lysine-specific demethylase 1 (LSD1) inhibitor currently being evaluated in multiple Phase 2 clinical trials.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott Laboratories

Amgen Inc.

Biogen Inc.

Eli Lilly and Company

Emergent Biosolutions Inc.

F. Hoffmann-La Roche Ltd

Johnson & Johnson

Lumen Bioscience Inc.

Merck & Co., Inc.

MigVax Ltd

Neurelis Inc.

Novo Nordisk A/S

Pfizer Inc.

Sanofi S.A.

Serum Institute of India Pvt. Ltd.

TransAlgae

Others

GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET, BY THERAPEUTIC PROTEIN TYPE- MARKET ANALYSIS, 2019 - 2032

Monoclonal Antibodies
Enzymes
Growth Factors
Interferons
Interleukins
Vaccines

GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032

Injection
Inhalation
Topical application

GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Cancer
Autoimmune Diseases
Infectious Diseases
Neurological Disorders
Metabolic Disorders
Other Diseases

GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Therapeutic Proteins and Oral Vaccines Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Therapeutic Proteins and Oral Vaccines Market Snippet by Therapeutic Protein Type
- 2.1.2. Therapeutic Proteins and Oral Vaccines Market Snippet by Delivery Method
- 2.1.3. Therapeutic Proteins and Oral Vaccines Market Snippet by Application
- 2.1.4. Therapeutic Proteins and Oral Vaccines Market Snippet by Country
- 2.1.5. Therapeutic Proteins and Oral Vaccines Market Snippet by Region
2.2. Competitive Insights

3. Therapeutic Proteins and Oral Vaccines Key Market Trends

3.1. Therapeutic Proteins and Oral Vaccines Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Therapeutic Proteins and Oral Vaccines Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Therapeutic Proteins and Oral Vaccines Market Opportunities
3.4. Therapeutic Proteins and Oral Vaccines Market Future Trends

4. Therapeutic Proteins and Oral Vaccines Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Therapeutic Proteins and Oral Vaccines Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Therapeutic Proteins and Oral Vaccines Market Landscape

6.1. Therapeutic Proteins and Oral Vaccines Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Therapeutic Proteins and Oral Vaccines Market - By Therapeutic Protein Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Therapeutic Protein Type, 2023 & 2032 (%)
- 7.1.2. Monoclonal Antibodies
- 7.1.3. Enzymes
- 7.1.4. Growth Factors
- 7.1.5. Interferons
- 7.1.6. Interleukins
- 7.1.7. Vaccines

8. Therapeutic Proteins and Oral Vaccines Market - By Delivery Method

8.1. Overview
- 8.1.1. Segment Share Analysis, By Delivery Method, 2023 & 2032 (%)
- 8.1.2. Injection
- 8.1.3. Inhalation
- 8.1.4. Topical application

9. Therapeutic Proteins and Oral Vaccines Market - By Application

9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 9.1.2. Cancer
- 9.1.3. Autoimmune Diseases
- 9.1.4. Infectious Diseases
- 9.1.5. Neurological Disorders
- 9.1.6. Metabolic Disorders
- 9.1.7. Other Diseases

10. Therapeutic Proteins and Oral Vaccines Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Therapeutic Proteins and Oral Vaccines Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Abbott Laboratories
- 11.2.2. Amgen Inc.
- 11.2.3. Biogen Inc.
- 11.2.4. Eli Lilly and Company
- 11.2.5. Emergent Biosolutions Inc.
- 11.2.6. F. Hoffmann-La Roche Ltd
- 11.2.7. Johnson & Johnson
- 11.2.8. Lumen Bioscience Inc.
- 11.2.9. Merck & Co., Inc.
- 11.2.10. MigVax Ltd
- 11.2.11. Neurelis Inc.
- 11.2.12. Novo Nordisk A/S
- 11.2.13. Pfizer Inc.
- 11.2.14. Sanofi S.A.
- 11.2.15. Serum Institute of India Pvt. Ltd.
- 11.2.16. TransAlgae
- 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us

简介目录图表

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Therapeutic Proteins and Oral Vaccines Market: Therapeutic Protein Type Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Therapeutic Protein Type
TABLE Global Therapeutic Proteins and Oral Vaccines Market, by Therapeutic Protein Type 2019-2032 (USD Million)
TABLE Therapeutic Proteins and Oral Vaccines Market: Delivery Method Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Delivery Method
TABLE Global Therapeutic Proteins and Oral Vaccines Market, by Delivery Method 2019-2032 (USD Million)
TABLE Therapeutic Proteins and Oral Vaccines Market: Application Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global Therapeutic Proteins and Oral Vaccines Market, by Application 2019-2032 (USD Million)
TABLE Therapeutic Proteins and Oral Vaccines Market: Regional snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Therapeutic Proteins and Oral Vaccines Market, by Region 2019-2032 (USD Million)
TABLE North America Therapeutic Proteins and Oral Vaccines Market, by Country, 2019-2032 (USD Million)
TABLE North America Therapeutic Proteins and Oral Vaccines Market, by Therapeutic Protein Type, 2019-2032 (USD Million)
TABLE North America Therapeutic Proteins and Oral Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
TABLE North America Therapeutic Proteins and Oral Vaccines Market, by Application, 2019-2032 (USD Million)
TABLE Europe Therapeutic Proteins and Oral Vaccines Market, by Country, 2019-2032 (USD Million)
TABLE Europe Therapeutic Proteins and Oral Vaccines Market, by Therapeutic Protein Type, 2019-2032 (USD Million)
TABLE Europe Therapeutic Proteins and Oral Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
TABLE Europe Therapeutic Proteins and Oral Vaccines Market, by Application, 2019-2032 (USD Million)
TABLE Asia Pacific Therapeutic Proteins and Oral Vaccines Market, by Country, 2019-2032 (USD Million)
TABLE Asia Pacific Therapeutic Proteins and Oral Vaccines Market, by Therapeutic Protein Type, 2019-2032 (USD Million)
TABLE Asia Pacific Therapeutic Proteins and Oral Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
TABLE Asia Pacific Therapeutic Proteins and Oral Vaccines Market, by Application, 2019-2032 (USD Million)
TABLE Latin America Therapeutic Proteins and Oral Vaccines Market, by Country, 2019-2032 (USD Million)
TABLE Latin America Therapeutic Proteins and Oral Vaccines Market, by Therapeutic Protein Type, 2019-2032 (USD Million)
TABLE Latin America Therapeutic Proteins and Oral Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
TABLE Latin America Therapeutic Proteins and Oral Vaccines Market, by Application, 2019-2032 (USD Million)
TABLE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market, by Country, 2019-2032 (USD Million)
TABLE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market, by Therapeutic Protein Type, 2019-2032 (USD Million)
TABLE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
TABLE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market, by Application, 2019-2032 (USD Million)

List of Figures

FIGURE Therapeutic Proteins and Oral Vaccines Market Segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter's Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparision Study
FIGURE Competitive Landscape; Key company market share analysis, 2023
FIGURE Therapeutic Protein Type segment market share analysis, 2023 & 2032
FIGURE Therapeutic Protein Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Delivery Method segment market share analysis, 2023 & 2032
FIGURE Delivery Method segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Application segment market share analysis, 2023 & 2032
FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Regional segment market share analysis, 2023 & 2032
FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE North America Therapeutic Proteins and Oral Vaccines Market share and leading players, 2023
FIGURE Europe Therapeutic Proteins and Oral Vaccines Market share and leading players, 2023
FIGURE Asia Pacific Therapeutic Proteins and Oral Vaccines Market share and leading players, 2023
FIGURE Latin America Therapeutic Proteins and Oral Vaccines Market share and leading players, 2023
FIGURE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market share and leading players, 2023
FIGURE North America market share analysis by country, 2023
FIGURE U.S. Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Canada Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Europe Therapeutic Proteins and Oral Vaccines Market share analysis by country, 2023
FIGURE Germany Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Spain Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Italy Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE France Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE UK Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Russia Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Netherlands Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Sweden Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Poland Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of the Europe Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Asia Pacific Therapeutic Proteins and Oral Vaccines Market share analysis by country, 2023
FIGURE India Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE China Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Japan Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE South Korea Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Australia Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Thailand Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Indonesia Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Philippines Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of APAC Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Latin America Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Latin America Therapeutic Proteins and Oral Vaccines Market share analysis by country, 2023
FIGURE Brazil Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Mexico Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Argentina Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Colombia Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of LATAM Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market share analysis by country, 2023
FIGURE Saudi Arabia Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE United Arab Emirates Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Israel Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Turkey Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Algeria Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Egypt Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of MEA Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)